Boston continues to be a major center for biopharma activity in the United States, with job application rates reaching a thirteen-month high in April 2026. Despite pressures on organizations to operate efficiently amid a cash-restricted environment, numerous companies of varying sizes are actively hiring across the city.
Syner-G is currently offering several positions in Boston, including project manager, validation engineer, and vice president of regulatory partnerships. The company also has engineering roles available in nearby Bedford.
Apogee Therapeutics is seeking an associate director for inflammation biology and lists dozens of additional remote roles. Eli Lilly and Company has 20 open positions across multiple departments.
Takeda is advertising more than 300 jobs spanning various departments in both Boston and Cambridge, as well as remote opportunities. Sanofi lists over 80 jobs in Cambridge alone, including head of toxicology innovation and global project head for solid tumor ADCs.
Formation Bio seeks a director for business development—search and evaluation—and also has openings in New York. Intellia Therapeutics offers 50 positions such as associate director, data architect, and vice president of gene editing core.
Additional companies with active hiring include Manus Bio in Waltham with roles like scientist—screening & analytical chemistry; Visterra, also based in Waltham, which has four scientist positions; Dyne Therapeutics with dozens of openings across several departments; ModeX Therapeutics featuring four roles including three associate directors and a global program lead based in Weston; and CSL with more than twelve openings across different departments.
